Group 1 - The core point of the article is that Jianfeng Group (600668) announced the approval of its subsidiary Jianfeng Beika's application for the chemical raw material drug Phosphate Tedizolid by the National Medical Products Administration [1] - Phosphate Tedizolid is a new antibacterial drug developed by Cubist Pharmaceuticals [1]